AHA to CMS Re: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021

The Centers for Medicare & Medicaid Services’ proposed rule on the standards governing health insurance issuers and the Health Insurance Marketplaces for 2021 includes a number of policies that could benefit patients by lowering drug prices and premiums, incentivizing use of high-value services and ensuring premium dollars are spent wisely, 

"We are concerned, however, that CMS continues to consider changes to automatic reenrollment, which could result in the loss of coverage for vulnerable enrollees and contribute to marketplace destabilization. “We are also concerned about the continued rise in annual cost-sharing limits, which many Americans already struggle to afford.”

AHA encourages the agency to “go further in future rulemaking to advance policies that will not only maintain the status quo but also build on the progress already made. Such policies include substantially increasing funding for outreach and enrollment efforts, extending the open enrollment period, and increasing lower- and middle-income individuals and families’ access to premium tax credits.”

Related Resources

Special Bulletin
A federal appeals court Dec. 18 ruled the Affordable Care Act’s individual mandate is unconstitutional, but it did not invalidate the entire law. The Fifth…
AHA's comments on the Department of Health and Human Services’ proposed rule to modify the current regulations implementing Section 1557 of the Affordable Care…
This supplemental report updates a previous analysis to reflect the revised Medicare-X Choice legislation as introduced in April, 2019.
AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act, which will help…
The AHA supports the administration’s goal of expanding access to coverage and increasing competition between health plans, but does not believe that efforts…
Statement of the American Hospital Association for the Committee on Rules of the U.S. House of Representatives “Medicare for All Act of 2019” April 30, 2019…